Rajthanee Hospital Public Company Limited
THB 16.30-THB 0.30 (-1.81%)
Rajthanee Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 6.32% below the high.
SET · AHC.BK · THB
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:17 AM UTC. Cached market data; not a live quote.
One-year closing-price history · THB. Historical prices are not a forecast.
Aikchol Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 25.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Aikchol Hospital Public Company Limited’s forward annual dividend is THB 0.52 per share, paid annual. The forward yield is 4.33% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aikchol Hospital Public Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1978 and based in Chonburi, Thailand, Aikchol Hospital Public Company Limited is a healthcare provider operating under the Aikchol Hospital brand. The company offers a full spectrum of medical and nursing services, including disease prevention, treatment, health enhancement, and rehabilitation, supported by its 310-bed facility. Its patient base is diverse, serving private individuals, policyholders from insurance companies, employees of corporate clients, and those enrolled in social security programs.
Latest available per-share figures in THB. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
THB 16.30-THB 0.30 (-1.81%)
Rajthanee Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 6.32% below the high.
THB 6.00-THB 0.05 (-0.83%)
Business Alignment Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
THB 18.70THB 0.00 (0.0%)
Nonthavej Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 25.2% below the high.
THB 4.84THB 0.00 (0.0%)
Inter Pharma Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 14.34% below the high.
THB 4.84THB 0.00 (0.0%)
Ratchaphruek Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 7.81% below the high.
THB 3.56-THB 0.02 (-0.56%)
Ladprao General Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 7.77% below the high.
THB 8.05-THB 0.05 (-0.62%)
Master Style Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 32.92% below the high.
THB 4.46-THB 0.02 (-0.45%)
Healthlead Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 42.08% below the high.